Specify a stock or a cryptocurrency in the search bar to get a summary
Si-Bone Inc
SIBNSI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California. Address: 471 El Camino Real, Santa Clara, CA, United States, 95050
Analytics
WallStreet Target Price
23.33 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures SIBN
Dividend Analytics SIBN
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History SIBN
Stock Valuation SIBN
Financials SIBN
Results | 2019 | Dynamics |